Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PCI Biotech Holding ASA ( (DE:4QG) ) has provided an announcement.
PCI Biotech Holding ASA has been placed in the Oslo Børs Recovery Box since 30 January 2026, a special compartment used when circumstances make pricing of a company’s securities particularly uncertain. The shares will remain there until the issues creating that uncertainty are resolved, signaling elevated risk and volatility for investors and complicating valuation.
The exchange also maintains a separate Penalty Bench for issuers that fail to comply with listing rules, although PCI Biotech is not currently on that list. Together, these designations underscore how Oslo Børs actively segments non-standard or higher-risk securities, which can influence liquidity, investor access, and market perception for affected companies.
More about PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norwegian listed company whose shares trade on Euronext Oslo Børs, placing it within the broader Nordic capital markets environment. The company is currently subject to special trading measures that affect how its securities are categorized and priced on the exchange.
YTD Price Performance: -43.90%
Average Trading Volume: 262,922
Current Market Cap: NOK5.15M
For an in-depth examination of 4QG stock, go to TipRanks’ Overview page.